Results 21 to 30 of about 4,610 (193)
Communications Medicine, 2022 Okawa et al. evaluate a fluorescent risedronate analogue, 800CW-pRIS, as a potential treatment for medication-related osteonecrosis of the jaw. The authors demonstrate an improvement in wound healing and inflammation with 800CW-pRIS pre-treatment in a ...
Hiroko Okawa +11 more
doaj +1 more source
Annali di Stomatologia, 2021 Bisphosphonate related osteonecrosis of the jaw (BRONJ) can occur in patients affected by malignancy associated hypercalcemia, bone metastases of solid tumors or multiple myeloma intaking amino-bisphosphonates or other bone resorption inhibitors.
A. Massaria +3 more
doaj +1 more source
Review and Update of the Risk Factors and Prevention of Antiresorptive-Related Osteonecrosis of the Jaw [PDF]
Endocrinology and Metabolism, 2021 Antiresorptive-related osteonecrosis of the jaw (ARONJ) is a rare but serious adverse event of bisphosphonate or denosumab administration; it is associated with severe pain and a deteriorated quality of life.
Ha Young Kim
doaj +1 more source
Pharmacogenetics of Bisphosphonate-associated Osteonecrosis of the Jaw [PDF]
Oral and Maxillofacial Surgery Clinics of North America, 2015 Osteonecrosis of the jaws (ONJ) is a potentially severe disorder that develops in a subgroup of individuals who have used bisphosphonate (BP) medications. Several clinical risk factors have been associated with the risk of ONJ development, but evidence is limited and in most instances ONJ remains an unpredictable adverse drug reaction.
Fung, PL +4 more
openaire +3 more sources
Mandibular Osteonecrosis Associated with Antacid Therapy (Esomeprazole)
European Journal of Case Reports in Internal Medicine, 2019 Introduction: Osteonecrosis of the jaw has been consistently reported in the literature associated to the high-dose intravenous bisphosphonate therapy. However, osteonecrosis can also occur in patients who have other risk factors.
Simone Marconcini +4 more
doaj +1 more source
Dental Implant Placement in Patients on Bisphosphonate Therapy: a Systematic Review
eJournal of Oral Maxillofacial Research, 2018 Objectives: The review aims to study dental implant placement purposefulness for patients who have been treated or are on treatment with bisphosphonate medication.
Rokas Gelazius +4 more
doaj +1 more source
Bisphosphonate-Related Osteonecrosis of the Jaw Mimicking Bone Metastasis
Case Reports in Oncological Medicine, 2014 Osteonecrosis of the jaw is usually a potential complication of bisphosphonate therapy. In a cancer patient, this disease entity can be misdiagnosed as a metastatic lesion. Our aim is to make clinicians aware of bisphosphonate associated osteonecrosis of
Geetika Bhatt +4 more
doaj +1 more source
eJournal of Oral Maxillofacial Research, 2017 Objectives: Osteonecrosis of the jaws is a side effect associated with the use of bisphosphonates. Using histologic analysis, this study aimed to evaluate the influence of microbial colonies in the development of osteonecrosis in the jaws of rats ...
Felipe M. Silveira +3 more
doaj +1 more source
Saudi Dental Journal, 2023 Objectives: It is not unusual for Medication-related osteonecrosis of the jaw (MRONJ) lesions that have similar clinical presentation and staging to have dissimilar radiographic extent of disease.
Ghaidaa Badabaan +4 more
doaj +1 more source
Haematologica, 2011 Osteonecrosis of the jaw is an uncommon but potentially serious complication of bisphosphonate therapy in multiple myeloma. Previous studies showed that the presence of one or two minor alleles of the cytochrome P450, subfamily 2C polypeptide 8 gene ...
Esperanza Such +13 more
doaj +1 more source